SEC Filings TLDR
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2025-10-28WNEB8-KWestern New England Bancorp Q3 2025 Earnings ReleaseearningsMEDIUM
Western New England Bancorp, Inc. reported its financial results for the quarter and nine months ended September 30, 2025. For the third quarter, the company posted net income of $3.2 million, or $0.16 per diluted share, compared to $1.9 million, or $0.09 per diluted share, in the same period last year. Total loans inc...
2025-10-28W8-KWayfair Q3 2025 Financial ResultsearningsMEDIUM
Wayfair Inc. announced its financial results for the third quarter ended September 30, 2025. The company reported total net revenue of $3.1 billion, an 8.1% increase year over year. U.S. net revenue grew by 8.6% to $2.7 billion, while international net revenue increased by 4.6% to $389 million. Gross profit was $934 mi...
2025-10-28WKC8-KWorld Kinect Corporation Announces Key Leadership Changes and Board Appointmentofficer / director changeMEDIUM
World Kinect Corporation reported significant leadership changes and a new board appointment in its 8-K filing dated October 22, 2025. The Board of Directors appointed Andrea B. Smith as a new director, effective October 24, 2025, increasing the board size from 10 to 11 members. Smith will serve on the Compensation and...
2025-10-28WELL8-KWelltower Inc. Announces $7.5 Billion At-The-Market Equity Offeringequity offeringHIGH
Welltower Inc. has entered into an equity distribution agreement to offer and sell shares of its common stock with an aggregate sales price of up to $7.5 billion. The shares may be sold through various sales agents and forward sellers, including BofA Securities, Inc., Goldman Sachs & Co. LLC, and J.P. Morgan Securities...
2025-10-28WPC8-KW. P. Carey Inc. Q3 2025 Earnings ReleaseearningsHIGH
W. P. Carey Inc. reported its financial results for the third quarter ended September 30, 2025. The company announced a net income of $141.0 million, or $0.64 per diluted share, and Adjusted Funds from Operations (AFFO) of $276.6 million, or $1.25 per diluted share. The company raised and narrowed its 2025 AFFO guidanc...
2025-10-28VOR8-KVor Biopharma Inc. 48-week Phase 3 Clinical Trial Data for Telitacicept in Primary Sjögren’s Diseaseoperation relatedHIGH
Vor Biopharma Inc. reported the results of a 48-week Phase 3 clinical trial for telitacicept in primary Sjögren’s disease. The trial, conducted in China, demonstrated statistically significant and clinically meaningful improvements in both physician-assessed and patient-reported outcomes. The primary endpoint was the c...
2025-10-28VANI8-KVivani Medical, Inc. Announces Private Placement and Registered Direct Offeringequity offeringMEDIUM
Vivani Medical, Inc. entered into a Share Purchase Agreement on October 26, 2025, with an entity affiliated with Gregg Williams, Chairman of the Company’s board of directors, for the purchase of 3,703,703 shares of common stock at $1.62 per share, resulting in gross proceeds of approximately $6.0 million. Concurrently,...
2025-10-28VST8-KVistra Corp. Completes Acquisition of Seven Natural Gas PlantsM&A / divestitureHIGH
On October 22, 2025, Vistra Corp. announced the completion of its acquisition of seven natural gas generation facilities from Lotus Infrastructure Partners. The acquisition, totaling approximately 2,600 MW of capacity, was finalized after receiving all necessary regulatory approvals. The transaction, valued at a base p...
2025-10-28VLTO8-KVeralto Corporation Q3 2025 Earnings ReleaseearningsHIGH
Veralto Corporation announced its financial results for the third quarter ended October 3, 2025. The company reported a 6.9% year-over-year increase in sales, reaching $1,404 million, with non-GAAP core sales growth of 5.1%. Operating profit margin stood at 23.2%, while non-GAAP adjusted operating profit margin was 23....
2025-10-28VSEEW8-KVSee Health, Inc. Announces 2025 Annual Meeting Detailsshareholder relatedMEDIUM
VSee Health, Inc. has announced the details for its 2025 Annual Meeting of Stockholders. The meeting is scheduled to take place on December 15, 2025, with the record date for determining eligible stockholders set as November 20, 2025. The company has established a deadline of November 7, 2025, for receiving stockholder...
2025-10-28V8-KVisa Inc. Fiscal Fourth Quarter and Full-Year 2025 Earnings ReleaseearningsHIGH
Visa Inc. reported its fiscal fourth quarter and full-year 2025 financial results. For the fourth quarter, the company achieved a GAAP net income of $5.1 billion, or $2.62 per share, and non-GAAP net income of $5.8 billion, or $2.98 per share. Net revenue for the quarter was $10.7 billion, a 12% increase year-over-year...
2025-10-28VRNS8-KVaronis Systems Q3 2025 Financial ResultsearningsMEDIUM
Varonis Systems, Inc. announced its financial results for the third quarter ended September 30, 2025. The company reported total revenues of $161.6 million, an increase from $148.1 million in the same quarter of the previous year. SaaS revenues were $125.8 million, up significantly from $57.8 million in Q3 2024. Howeve...
2025-10-28VFC8-KV.F. Corporation Q2 Fiscal 2026 Earnings ReleaseearningsHIGH
V.F. Corporation reported its financial results for the second quarter of Fiscal 2026, ending September 27, 2025. The company announced a quarterly dividend of $0.09 per share. Revenue for the quarter was $2.8 billion, a 2% increase year-over-year (YoY) or a 1% decrease on a constant currency basis. The North Face® and...
2025-10-28PRKS8-KResignation and Appointment of Chief Financial Officer at United Parks & Resorts Inc.officer / director changeMEDIUM
On October 22, 2025, James Mikolaichik resigned from his position as Chief Financial Officer and Treasurer of United Parks & Resorts Inc., effective November 15, 2025. His resignation was not due to any disagreements with the company regarding financial statements, internal controls, operations, policies, or practices....
2025-10-28UNCY8-KUnicycive Therapeutics Provides Update on FDA Meeting and NDA Resubmissionregulatory investigationMEDIUM
Unicycive Therapeutics, Inc. announced an update from its meeting with the U.S. Food and Drug Administration (FDA) regarding the resubmission of its New Drug Application (NDA) for Oxylanthanum Carbonate (OLC). The company plans to resubmit the NDA by the end of 2025, following the resolution of a manufacturing complian...
2025-10-28UCTT8-KUltra Clean Holdings Q3 2025 Financial Results and Share Repurchase ProgramearningsMEDIUM
Ultra Clean Holdings, Inc. (UCT) reported its financial results for the third quarter ended September 26, 2025. The company achieved total revenue of $510.0 million, with products contributing $445.0 million and services adding $65.0 million. The gross margin was 16.1%, operating margin was 2.1%, and net loss was $(10....
2025-10-28USCB8-KUSCB Financial Holdings Q3 2025 Investor Presentationoperation relatedMEDIUM
USCB Financial Holdings, Inc. filed an investor presentation for the third quarter of 2025, highlighting key financial metrics and strategic initiatives. The company reported a net income of $8.9 million, an 18.3% increase in average deposits, and an 11.8% increase in average loans compared to the same period in 2024. ...
2025-10-28UHS8-KUniversal Health Services, Inc. Announces Q3 2025 Financial Results and Increases Stock Repurchase ProgramearningsHIGH
Universal Health Services, Inc. (UHS) reported its financial results for the third quarter of 2025, showing significant growth in net income and revenues. The company announced a net income attributable to UHS of $373.0 million, or $5.86 per diluted share, compared to $258.7 million, or $3.80 per diluted share, in the ...
2025-10-28UNH8-KUnitedHealth Group Q3 2025 Earnings ReleaseearningsHIGH
UnitedHealth Group reported its third quarter 2025 results, showing a 12% year-over-year increase in revenues to $113.2 billion. The company announced earnings of $2.59 per share and adjusted earnings of $2.92 per share. Cash flows from operations were $5.9 billion, or 2.3 times net income. UnitedHealth Group raised it...
2025-10-28UPS8-KUPS Q3 2025 Earnings ReleaseearningsMEDIUM
United Parcel Service, Inc. (UPS) reported its third-quarter 2025 financial results, with consolidated revenues of $21.4 billion, a 3.7% decrease compared to the same period in 2024. The company's consolidated operating profit was $1.8 billion, with a non-GAAP adjusted operating profit of $2.1 billion. Diluted earnings...
2025-10-28UMBF8-KUMB Financial Corporation Q3 2025 Earnings ReleaseearningsHIGH
UMB Financial Corporation reported its financial results for the third quarter of 2025, highlighting a significant increase in net income available to common shareholders, which rose to $180.4 million, or $2.36 per diluted share, compared to $109.6 million, or $2.23 per diluted share, in the same period last year. The ...
2025-10-28ULS8-KUL Solutions Inc. Enters into $1 Billion Credit Agreementdebt financingMEDIUM
On October 28, 2025, UL Solutions Inc. entered into a $1.0 billion senior unsecured five-year multi-currency revolving credit facility with Bank of America, N.A., as administrative agent, and other lenders. The credit agreement includes a $25 million sub-limit for letters of credit and an accordion feature allowing for...
2025-10-28DJTWW8-KTrump Media & Technology Group Corp. Announces Prediction Markets on Truth Socialoperation relatedHIGH
Trump Media & Technology Group Corp. announced that it will make prediction markets available on its social media platform, Truth Social, through an exclusive arrangement with Crypto.com | Derivatives North America (CDNA). This integration will allow users to trade prediction contracts related to major events such as p...
2025-10-28TRML8-KCompletion of Merger Between Tourmaline Bio, Inc. and Novartis AGM&A / divestitureHIGH
Tourmaline Bio, Inc. has completed its previously announced merger with Novartis AG, as per the Agreement and Plan of Merger dated September 8, 2025. The merger was effected through a cash tender offer by Torino Merger Sub Inc., an indirect wholly owned subsidiary of Novartis AG, to acquire all outstanding shares of To...
2025-10-28TRMK8-KTrustmark Q3 2025 Financial Results: Earnings Growth and Capital StrengthearningsHIGH
Trustmark Corporation reported net income of $56.8 million for Q3 2025, with diluted earnings per share of $0.94. Key highlights include a 3.4% year-over-year loan growth (reaching $13.5 billion) and a 2.6% annual increase in deposits ($15.6 billion). Revenue grew 5.3% year-over-year to $202.4 million, driven by a 4.6%...